Yahoo Finance

Prometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck

Pharma goliath, Merck MRK and Prometheus Biosciences, Inc RXDX, together announced entering a definitive agreement where the former is set to acquire the latter, through a subsidiary for $200 per ...
PAROOL

Directeur van Prometheus Mai Spijkers onder vuur om intimidatie en machtsmisbruik

Mai Spijkers, directeur van Prometheus, zou werknemers regelmatig uitschelden, seksistische opmerkingen maken en zijn personeel veel overuren laten draaien. De Volkskrant sprak twintig mensen die ...
Inc

How Mark Zuckerberg Is Going to Power Meta’s New AI Supercluster, Prometheus

CEO Mark Zuckerberg took to social-media network Threads on Monday to confirm reports that Meta is working to bring its 1 gigawatt (GW) AI supercluster, called Prometheus, online by 2026. The company ...
Yahoo Finance

Prometheus Biosciences Announces Positive Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies Enabling Pathway to Both First-in-Class and Best-in-Class ...

SAN DIEGO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development ...
Reuters

Merck to buy Prometheus Biosciences for about $11 billion

April 16 (Reuters) - Merck & Co (MRK.N), opens new tab said on Sunday it will buy Prometheus Biosciences Inc (RXDX.O), opens new tab for about $10.8 billion, picking up a promising experimental ...
STAT

Merck to acquire Prometheus Biosciences, maker of autoimmune drugs, for $10.8 billion

Merck said Sunday that it will acquire Prometheus Biosciences for $10.8 billion, adding a pipeline of experimental drugs to treat immune-related diseases. The deal values Prometheus at $200 per share, ...